Akoya Biosciences, Inc.

NasdaqGS:AKYA 株式レポート

時価総額:US$104.6m

Akoya Biosciences 将来の成長

Future 基準チェック /16

Akoya Biosciencesは、28.3%と9%でそれぞれ年率28.3%で利益と収益が成長すると予測される一方、EPSはgrowで32.5%年率。

主要情報

28.3%

収益成長率

32.5%

EPS成長率

Life Sciences 収益成長18.4%
収益成長率9.0%
将来の株主資本利益率n/a
アナリストカバレッジ

Good

最終更新日18 Nov 2024

今後の成長に関する最新情報

Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported, And Analysts Assigned A US$5.42 Price Target

Aug 09
Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported, And Analysts Assigned A US$5.42 Price Target

Recent updates

Revenue Downgrade: Here's What Analysts Forecast For Akoya Biosciences, Inc. (NASDAQ:AKYA)

Nov 19
Revenue Downgrade: Here's What Analysts Forecast For Akoya Biosciences, Inc. (NASDAQ:AKYA)

Is Akoya Biosciences (NASDAQ:AKYA) Using Too Much Debt?

Nov 12
Is Akoya Biosciences (NASDAQ:AKYA) Using Too Much Debt?

Akoya Biosciences, Inc. (NASDAQ:AKYA) Stock Rockets 36% But Many Are Still Ignoring The Company

Oct 08
Akoya Biosciences, Inc. (NASDAQ:AKYA) Stock Rockets 36% But Many Are Still Ignoring The Company

Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported, And Analysts Assigned A US$5.42 Price Target

Aug 09
Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported, And Analysts Assigned A US$5.42 Price Target

Market Might Still Lack Some Conviction On Akoya Biosciences, Inc. (NASDAQ:AKYA) Even After 31% Share Price Boost

Jun 27
Market Might Still Lack Some Conviction On Akoya Biosciences, Inc. (NASDAQ:AKYA) Even After 31% Share Price Boost

Is Akoya Biosciences (NASDAQ:AKYA) A Risky Investment?

Jun 24
Is Akoya Biosciences (NASDAQ:AKYA) A Risky Investment?

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO For Now

May 29
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO For Now

Investors Continue Waiting On Sidelines For Akoya Biosciences, Inc. (NASDAQ:AKYA)

May 10
Investors Continue Waiting On Sidelines For Akoya Biosciences, Inc. (NASDAQ:AKYA)

Is Akoya Biosciences (NASDAQ:AKYA) Weighed On By Its Debt Load?

Feb 28
Is Akoya Biosciences (NASDAQ:AKYA) Weighed On By Its Debt Load?

Investors Still Aren't Entirely Convinced By Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Despite 31% Price Jump

Nov 25
Investors Still Aren't Entirely Convinced By Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Despite 31% Price Jump

Akoya Biosciences Seeks Growth Despite Higher Operating Losses

May 30

Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 11
Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

業績と収益の成長予測

NasdaqGS:AKYA - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/2026106-24-17-67
12/31/202591-32-16-97
12/31/202482-56-43-437
9/30/202487-58-49-47N/A
6/30/202493-60-54-51N/A
3/31/202494-68-56-52N/A
12/31/202397-63-55-51N/A
9/30/202391-71-59-55N/A
6/30/202385-76-61-54N/A
3/31/202379-73-62-55N/A
12/31/202275-71-61-53N/A
9/30/202270-69-57-49N/A
6/30/202264-63-57-51N/A
3/31/202260-51-55-50N/A
12/31/202155-44-41-36N/A
9/30/202152-34-37-32N/A
6/30/202148-28-24-21N/A
3/31/202144-28-13-10N/A
12/31/202042-22-10-7N/A
12/31/201942-18-17-14N/A

アナリストによる今後の成長予測

収入対貯蓄率: AKYA今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: AKYA今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: AKYA今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: AKYAの収益 ( 9% ) US市場 ( 8.9% ) よりも速いペースで成長すると予測されています。

高い収益成長: AKYAの収益 ( 9% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: AKYAの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘